WaveLight

Erlangen, Germany Founded: 1996 • Age: 30 yrs Acquired By Alcon
Diagnostic and surgical technologies for vision correction are provided.

About WaveLight

WaveLight is a Healthcare company based in Erlangen (Germany) founded in 1996, and was acquired by Alcon in July 2007. It operates as a diagnostic and surgical technologies for vision correction are provided. The company has 320 employees. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is Alcon Deutschland GmbH. Its competitors include Clerio Vision, IntraLase, Kejako, Technolas Perfect Vision and Xianwei Vision Technology and 4 more; 4 of its 9 listed competitors have raised funding.

Company details

WaveLight GmbH was founded in 1996 in Erlangen, Germany, as a subsidiary of Alcon within the Novartis Group. Operations focus on the development and production of diagnostic and surgical technologies for laser eye surgery in the ophthalmology sector. The product portfolio includes electronic management systems for intraocular lens positioning during cataract operations and eye tracking systems for vision correction procedures.

  • Headquarters Erlangen, Germany
  • Employees 320
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website wavelight.de
  • Social LinkedIn
  • Acquired by Alcon (Jul 2007)
  • Legal Name Alcon Deutschland Gmbh
Operational Areas
Key Metrics

Investors in WaveLight

WaveLight has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Alcon.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Developer of a wide range of eye care products
1945alcon.comFort Worth, United States
Premium access

Investor details for WaveLight

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of WaveLight

2 dated milestones of WaveLight across 11 years, from founding to its latest funding, stage changes and deals.

  1. Founded WaveLight is founded.
  2. Exit Acquired by Alcon.

Competitors of WaveLight

WaveLight has 9 listed competitors in our database, 4 of them funded. They include Clerio Vision, IntraLase, Kejako, Technolas Perfect Vision and Xianwei Vision Technology, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cleriovision.com2014Rochester, United States$28.95M90
Laser induced change in refractive index
intralase.com1997Irvine, United States$29.5M–
Femtosecond laser technology is developed for eye surgery procedures.
kejako.com2015–$807,476–
Medical devices for ophthalmic surgery are researched and developed.
technolaspv.com2008Munich, Germany–163
Femtosecond and excimer lasers for ophthalmology are designed and produced.
xianweivisiontechnology.tcc.mode2022Nanjing, China––
Femtosecond laser-based devices for ophthalmic myopia correction are developed.
customvis.com2001Perth, Australia––
Surgical laser vision correction technology is provided for ophthalmologists.
lenticularresearchgroup.com2007Naperville, United States$330,000–
Developer of laser device for treating the cause of presbyopia
optotek-medical.com1990Ljubljana, Slovenia––
Optical and laser solutions for ophthalmic treatments are developed.
tklaser.com2006Tianjin, China––
Manufactures and supplies medical lasers.
Premium access

Detailed competitors of WaveLight

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Ophthalmology

10 companies that operate in the same segment as WaveLight (Ophthalmology), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of a wide range of eye care products
1945Fort Worth, Texas, United StatesUSD 171.61 MUSD 9.64 B25,600
Genetic medicines are developed by 4DMT for transformative therapies.
2013Emeryville, California, United StatesUSD 186.59 MUSD 85.21 M227
Developer of antibodies to treat complement-mediated neurodegenerative diseases
2011San Francisco, California, United StatesUSD 256 M–100
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
2003Alpharetta, Georgia, United StatesUSD 66.8 MUSD 80.75 M79
AI-powered portable solutions for ophthalmic screening and diagnosis are developed.
2009Bengaluru, Karnataka, IndiaUSD 25.01 MUSD 4.85 M135
Gene therapies for ocular and neurodegenerative diseases are developed.
2015New York, New York, United States–USD 81.39 M381
Small molecule therapeutics for ophthalmic disorders are developed.
1987Watertown, United States–USD 31.37 M165
Therapies for metabolic and orphan diseases are developed by Rezolute.
2012Denver, Colorado, United States––59
Manufacturer of portable digital eye imaging devices and cloud-based healthcare platforms
2010Bengaluru, Karnataka, IndiaUSD 18.12 MUSD 4.78 M145
Therapeutics for retinal diseases are developed by the company.
2009Palo Alto, California, United StatesUSD 35.84 M–109
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about WaveLight

WaveLight was founded in 1996.

WaveLight is headquartered in Erlangen, Germany. It is registered at Erlangen, Bavaria, Germany.

WaveLight has 320 employees.

WaveLight GmbH was founded in 1996 in Erlangen, Germany, as a subsidiary of Alcon within the Novartis Group. Operations focus on the development and production of diagnostic and surgical technologies for laser eye surgery in the ophthalmology sector. The product portfolio includes electronic management systems for intraocular lens positioning during cataract operations and eye tracking systems for vision correction procedures.

WaveLight's top competitors include Clerio Vision, IntraLase and Technolas Perfect Vision.

WaveLight has 1 investor. Key investors include Alcon.

WaveLight operates through Alcon Deutschland Gmbh.

Yes. WaveLight was acquired by Alcon in July 2007.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available